Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Clinical Research
The World on Trial
Johnson & Johnson's Janet Flisak talks to NGP's Matt Buttell about completing clinical trials on an international landscape, discussing the difficulties associated with patient recruitment.
Building Relationships Around the Globe
Wyeth’s Joan Shen examines the benefits of choosing international locations for clinical trials.
Leaping the Hurdles
As patents expire and pipelines are pressured, NGP finds out how Lundbeck’s Peter Høngaard Andersen is working to stay at the front of the R&D race.
Determination of CSF Biomarkers in Alzheimer Disease
Alzheimer’s disease (AD) is the leading cause of dementia among people aged 65 and older. The disease is characterized by a slow progressive loss of cognition, behavioral changes and loss of independence that ends in the complete destruction of the personality (Arnold et al, 1991). By Eurofins Medinet
Early Phase Research – The Problem, the Pathway, and the Higher Value Outcome
Members of product development teams typically visit the Phase I-II world every few years. Increasingly, however, they are finding it a different world at each visit, due to a variety of trends. By Royce Morrison of Charles River Laboratories
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.